주식/증권 ➡️ 중립 Seastar Medical targets about $2M 2026 QUELIMMUNE revenue while aiming to finish NEUTRALIZE-AKI enrollment by end of 2026 Seeking Alpha - Market News 2026/05/13 22:51:32 14회 원문 기사 보기